<DOC>
	<DOCNO>NCT02853643</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability , determine blood level ( pharmacokinetics ) , fed fasted condition , single dose ASN002 . Healthy volunteer participant study .</brief_summary>
	<brief_title>Single Ascending Dose Study Evaluate Pharmacokinetics Food-Effect Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>1 . Healthy male female , nonsmoking subject . 2 . Willing use contraception throughout duration study 90 day study . 3 . Capable consent . Subjects follow applies exclude study : 1 . Any clinically significant abnormality , infection , exposure infection , recent live virus vaccination , abnormal laboratory test result find medical screening . 2 . History alcohol drug abuse , positive urine drug screen breath alcohol test screening . 3 . History allergic reaction protein kinase inhibitor , significant allergic reaction drug . 4 . Positive pregnancy test screening . 5 . Clinically significant ECG abnormality . 6 . Participation clinical research study involve administration investigational market drug device within 30 day prior first dosing , administration biological product context clinical research study within 90 day prior first dosing , concomitant participation investigational study involve drug device administration . 7 . Use medication topical product without significant systemic absorption : 8 . Donation plasma within 7 day prior dose , significant blood loss within past 56 day . 9 . Subject pregnant , breast feeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>